Skip to Content
Symphonies
Top Patent Approvals 2010-2017
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

Own 25 companies that consistently received the most patents in 2010–2017. Equal-weighted, rebalanced quarterly. Heavy in chipmakers and software (TSMC, Intel, Microsoft) plus industrial, consumer, and medical innovators (GE, P&G, Medtronic, Nike).
NutHow it works
We look at how many patents each company had approved each year from 2010–2017. Each year we rank all companies; then we average each company’s ranks across those years. We buy the 25 with the best average ranks in equal size. Every 3 months, we reset back to equal weights and refresh the list if needed.
CheckmarkValue prop
Out-of-sample edge: 15.28% annualized return vs S&P 13.99%, from a 25-name equal-weight, patent-driven portfolio rebalanced quarterly. Captures ongoing innovation upside with diversification—albeit with higher beta and drawdowns.
1M
3M
6M
YTD
1Y
3Y
Max
www.composer.trade
Performance
Compared to selected benchmarks
AlphaBetaR2R
SPY
01.120.880.94
Performance Metrics
Cumulative ReturnAnnualized ReturnTrailing 1M ReturnTrailing 3M ReturnSharpe Ratio
SPY
647.56%14.34%1.36%5.73%0.87
Top Patent Approvals 2010-2017
850.91%16.18%1.86%9.74%0.84
Initial Investment
$10,000.00
Final Value
$95,091.02
Regulatory Fees
$3.88
Total Slippage
$21.97
Invest in this strategy
OOS Start Date
Feb 13, 2022
Trading Setting
Quarterly
Type
Stocks
Category
Innovation, patents, equities, equal-weight, quarterly rebalance, tech-heavy, multi-sector, global adrs
Tickers in this symphonyThis symphony trades 0 assets in total
Ticker
Type

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"Top Patent Approvals 2010-2017" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"Top Patent Approvals 2010-2017" is currently allocated toLPL, MU, AMAT, AVGO, INTC, QCOM, TXN, GE, HON, SAP, LPLA, HMC, BA, AAPL, ORCL, SONY, XRX, TSM, MDT, PG, MSFT, NKE, IBMandBKR. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "Top Patent Approvals 2010-2017" has returned 15.28%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "Top Patent Approvals 2010-2017" is 29.46%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "Top Patent Approvals 2010-2017", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, crypto, and options.